CHAN, S., ROMIEU, G., MAYORDOMO, J. I., ANTON, A., HARRISON, M., JONES, A., . . . KREIENBERG, R. (2009). Phase III Study of Gemcitabine Plus Docetaxel Compared With Capecitabine Plus Docetaxel for Anthracycline-Pretreated Patients With Metastatic Breast Cancer. Journal of clinical oncology, 27(11), 1753-1760. https://doi.org/10.1200/JCO.2007.15.8485
Chicago Style (17th ed.) CitationCHAN, Stephen, et al. "Phase III Study of Gemcitabine Plus Docetaxel Compared With Capecitabine Plus Docetaxel for Anthracycline-Pretreated Patients With Metastatic Breast Cancer." Journal of Clinical Oncology 27, no. 11 (2009): 1753-1760. https://doi.org/10.1200/JCO.2007.15.8485.
MLA (9th ed.) CitationCHAN, Stephen, et al. "Phase III Study of Gemcitabine Plus Docetaxel Compared With Capecitabine Plus Docetaxel for Anthracycline-Pretreated Patients With Metastatic Breast Cancer." Journal of Clinical Oncology, vol. 27, no. 11, 2009, pp. 1753-1760, https://doi.org/10.1200/JCO.2007.15.8485.